Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 297 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATENOLOL | 50MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1797 |
| RATIO-ATORVASTATIN | 40MG | TABLET | Actual shortage | 2017-03-13 | 2017-10-10 | 1803 |
| RATIO-ATORVASTATIN | 80MG | TABLET | Actual shortage | 2017-03-14 | 2018-12-21 | 2343 |
| RATIO-ATORVASTATIN | 80MG | TABLET | Actual shortage | 2017-05-23 | 2017-10-05 | 10883 |
| TEVA-CARVEDILOL | 12.5MG | TABLET | Resolved | 2017-03-14 | 2017-05-23 | 2359 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2017-03-10 | 2017-11-07 | 167 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Resolved | 2017-03-14 | 2017-11-06 | 2370 |
| TEVA-CLOBETASOL | 0.05% | CREAM | Resolved | 2017-09-21 | 2017-11-06 | 22942 |
| RATIO-DOCUSATE SODIUM | 20MG | SYRUP | Resolved | 2020-03-12 | 2020-04-23 | 108604 |
| RATIO-DOCUSATE SODIUM | 20MG | SYRUP | Resolved | 2023-07-04 | 2024-02-07 | 197195 |
| RATIO-DOCUSATE SODIUM | 20MG | SYRUP | Resolved | 2020-11-12 | 2021-01-21 | 128327 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2017-03-14 | 2018-02-21 | 2374 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2017-03-14 | 2018-03-08 | 2380 |
| TEVA-ECTOSONE | 0.05% | LOTION | Resolved | 2017-09-21 | 2018-03-07 | 22945 |
| TEVA-ECTOSONE | 0.1% | CREAM | Resolved | 2018-03-13 | 2018-10-11 | 42622 |
| TEVA-ECTOSONE | 0.1% | LOTION | Resolved | 2017-08-14 | 2018-01-03 | 19304 |
| RATIO-IPRA SAL UDV | 0.5MG 2.5MG | SOLUTION | Resolved | 2017-03-17 | 2017-07-28 | 3137 |
| RATIO-IPRA SAL UDV | 0.5MG 2.5MG | SOLUTION | Resolved | 2019-07-02 | 2019-07-16 | 88167 |
| RATIO-IPRATROPIUM UDV | 250MCG | SOLUTION | Resolved | 2017-05-23 | 2017-09-19 | 10892 |
| TEVA-IRBESARTAN | 150MG | TABLET | Resolved | 2017-08-14 | 2017-09-19 | 19308 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152351 |
| TEVA-AMLODIPINE | 10MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120039 |
| TEVA-AMLODIPINE | 5MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120036 |
| TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104283 |
| TEVA-ARIPIPRAZOLE | 30MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117541 |
| TEVA-ARIPIPRAZOLE | 10MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117535 |
| TEVA-ARIPIPRAZOLE | 15MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117538 |
| TEVA-ARIPIPRAZOLE | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117532 |
| TEVA-ARIPIPRAZOLE | 2MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115085 |
| TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104263 |
| TEVA-ARIPIPRAZOLE | 15MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97264 |
| TEVA-ARIPIPRAZOLE | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97267 |
| TEVA-ATENOLOL | 100MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106145 |
| TEVA-ATENOLOL | 50MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106142 |
| TEVA-ATENOLOL/CHLORTHALIDONE | 25MG 100MG | TABLET | Discontinued | 2020-01-21 | 2020-01-21 | 103781 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |